withdrawn in 2018), tirzepatide (Mounjaro for type II diabetes and Zepbound for obesity, a dual GIP/GLP1 receptor agonist administered at up to 15 mg once weekly), and semaglutide (Ozempic for type II diabetes at up to 2 mg once weekly, and Wegovy for obesity at 2.4 mg once weekly
Aliquot after reconstitution and keep cold to preserve peptide integrity across a multi-week study window
J Urol 213:e328 Feghali K, Li X, Maalouf NM (2024) Changes in 24-hour urine chemistry in patients with nephrolithiasis during weight loss with glucagon-like peptide 1-based therapies
100% online telehealth consultations - no waiting rooms Transparent pricing with no hidden fees or subscriptions FDA-regulated US pharmacies (503A and 503B facilities) Board-certified, independent healthcare providers Free expedited shipping direct to your door Ongoing care team support How It Works Complete a secure online health questionnaire (5 minutes) A licensed provider reviews your information within 24-48 hours If approved, your prescription is sent to our partner pharmacy Medication ships directly to you with free expedited shipping Frequently Asked Questions What is Rift
83% of members sustain results for one year* 1.4M pounds lost by Found members It's not just about the weight you've lost, it's about the life you've found
Your doctor may suggest that you test for Vitamin B12 deficiency
